Clinical Trials Browser

Phase 1/2 × OTHER × sargramostim × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

PNeoVCA

Tebentafusp-tebn With LDT in Metastatic UM

STING

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

REO13 Melanoma With of Without GM-CSF

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

CHOP-R

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant